Cancer Hospital, Chinese Academy of Medical Sciences
Introduction
Cancer Hospital, Chinese Academy of Medical Sciences, is a Grade 3A cancer specialty hospital under the National Health Commission and the first cancer specialty hospital established in New China. Founded in 1958 and originally named Ritan Hospital, it serves as the National Clinical Research Center for Malignant Tumors, the National Quality Control Center for Standardized Cancer Diagnosis and Treatment, the National Clinical Research Center for Drugs, the National Quality Evaluation and Promotion Center for Clinical Research, and the host site of the National Anti-tumor Drug Monitoring Network. It is a national-level cancer prevention and treatment center integrating medical services, education, research, and prevention. The hospital has 5 national key disciplines and 6 national clinical key specialties. In the performance assessment of national tertiary public hospitals, it has consistently ranked first among national tertiary cancer specialty hospitals, with the national monitoring indicator grade reaching the highest level A for specialty hospitals. The hospital receives over one million outpatient visits annually and performs more than 30,000 surgeries each year. While the volume of medical services continues to grow, multiple quality evaluation indicators—such as the five-year survival rate of treated patients, average length of stay, proportion of grade-4 surgeries, and case mix index—rank first among national cancer specialty hospitals. The hospital provides comprehensive cancer treatments including surgery (including minimally invasive and endoscopic procedures), chemotherapy, radiotherapy, and interventional therapy. Its multidisciplinary standardized comprehensive treatment leads the nation, with some areas reaching international advanced levels. It has pioneered innovative medical technologies in China, such as Hmarker precise localization of pulmonary nodules, anatomical segmentectomy, natural orifice specimen extraction surgery, robotic/laparoscopic radical cystectomy with orthotopic neobladder, and hypofractionated radiotherapy. The hospital is equipped with advanced instruments and devices, including a proton accelerator, MR-guided medical linear accelerator, rotational intensity-modulated radiotherapy linear accelerator, ultra-high-end spectral CT, 3T high-field functional MRI, and PET-MRI. Entrusted by the National Health Commission, it has led the development and revision of 33 diagnosis and treatment guidelines for individual cancer types in recent years.
Related Diseases
No related diseases listed yet.
Related Doctors
No related doctors listed yet.